ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin; thiamine hydrochloride; vitamin a; vitamin e
Drug data last refreshed 9h ago · AI intelligence enriched 1w ago
M.V.I.-12 ADULT is a parenteral multivitamin injection containing 12 essential vitamins (A, B-complex, C, D, E) used to prevent or treat vitamin deficiencies in patients unable to take oral supplementation. This fixed-dose combination replaces depleted micronutrients in hospitalized, critically ill, or nutritionally compromised patients receiving parenteral nutrition or long-term IV therapy.
This legacy parenteral vitamin product faces moderate competitive pressure (30% intensity) as it approaches loss of exclusivity, limiting team expansion opportunities and focusing roles on efficiency and cost management rather than growth.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on M.V.I.-12 ADULT offers limited career growth opportunity as the product approaches LOE with zero linked job openings and a mature market with modest commercial intensity. This role is best suited for professionals seeking stability in hospital product management or those transitioning toward supply-chain and cost-optimization expertise.
Worked on M.V.I.-12 ADULT at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.